Compare TNYA & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNYA | JFIN |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | China |
| Employees | 70 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 149.7M |
| IPO Year | 2021 | 2018 |
| Metric | TNYA | JFIN |
|---|---|---|
| Price | $0.77 | $2.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 69.2K |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | N/A | ★ 17.47% |
| EPS Growth | ★ 54.96 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $2.15 |
| 52 Week High | $2.35 | $14.70 |
| Indicator | TNYA | JFIN |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 19.23 |
| Support Level | $0.65 | N/A |
| Resistance Level | $0.80 | $4.54 |
| Average True Range (ATR) | 0.06 | 0.18 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 10.91 | 1.46 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.